BTC$80,701.94▲ 4.92%ETH$2,426.26▲ 7.27%USDT$0.9993▲ 0.04%BNB$718.69▲ 3.81%XRP$1.31▲ 4.38%USDC$1.00▲ 0.01%SOL$95.94▲ 4.58%TRX$0.3197▼ 0.83%FIGR_HELOC$1.05▲ 1.54%ZEC$1,305.37▲ 8.75%HYPE$84.10▲ 2.61%DOGE$0.0770▲ 4.33%XMR$118.70▲ 1.54%USDS$1.00▲ 0.02%WBT$77.97▲ 5.57%LINK$11.44▲ 5.54%LEO$9.36▲ 0.21%ADA$0.1971▲ 5.72%XLM$0.1681▲ 5.55%BCH$282.40▲ 4.52%NEAR$4.02▲ 6.70%UNI$7.64▲ 8.40%DAI$1.00▲ 0.01%USDE$1.00▲ 0.06%LTC$56.18▲ 5.65%RAIN$0.005979▼ 7.72%CC$0.1002▲ 3.92%AVAX$8.74▲ 4.38%SUI$0.9306▲ 6.20%USD1$0.9994▲ 0.04%GRAM$1.17▲ 1.23%XAUT$4,106.38▲ 3.72%HBAR$0.0729▲ 6.51%QNT$203.01▲ 6.80%USDG$1.00▲ 0.02%SHIB$0.000005▲ 4.10%TAO$236.30▲ 6.79%PYUSD$1.00▲ 0.02%CRO$0.0522▲ 5.10%RLUSD$1.00▲ 0.02%BTC$80,701.94▲ 4.92%ETH$2,426.26▲ 7.27%USDT$0.9993▲ 0.04%BNB$718.69▲ 3.81%XRP$1.31▲ 4.38%USDC$1.00▲ 0.01%SOL$95.94▲ 4.58%TRX$0.3197▼ 0.83%FIGR_HELOC$1.05▲ 1.54%ZEC$1,305.37▲ 8.75%HYPE$84.10▲ 2.61%DOGE$0.0770▲ 4.33%XMR$118.70▲ 1.54%USDS$1.00▲ 0.02%WBT$77.97▲ 5.57%LINK$11.44▲ 5.54%LEO$9.36▲ 0.21%ADA$0.1971▲ 5.72%XLM$0.1681▲ 5.55%BCH$282.40▲ 4.52%NEAR$4.02▲ 6.70%UNI$7.64▲ 8.40%DAI$1.00▲ 0.01%USDE$1.00▲ 0.06%LTC$56.18▲ 5.65%RAIN$0.005979▼ 7.72%CC$0.1002▲ 3.92%AVAX$8.74▲ 4.38%SUI$0.9306▲ 6.20%USD1$0.9994▲ 0.04%GRAM$1.17▲ 1.23%XAUT$4,106.38▲ 3.72%HBAR$0.0729▲ 6.51%QNT$203.01▲ 6.80%USDG$1.00▲ 0.02%SHIB$0.000005▲ 4.10%TAO$236.30▲ 6.79%PYUSD$1.00▲ 0.02%CRO$0.0522▲ 5.10%RLUSD$1.00▲ 0.02%

Enlivex Therapeutics (Ondo Tokenized) vs SpaceX (bStocks Tokenized Stock)

SpaceX (bStocks Tokenized Stock) (SPCXB) is 97944.0× the size of Enlivex Therapeutics (Ondo Tokenized) (ENLVON) by market capitalisation. Their daily returns move barely together (correlation 0.06 across 28 shared trading days). ENLVON has been the more volatile of the two, at 485% annualised against SPCXB's 71%.

Correlation
0.06
Size ratio
1 : 97944.0
Enlivex Therapeutics (Ondo Tokenized)ENLVON

$0.006099

24h
+1.53%
Market cap
$2,005
Volume 24h
$83
Volatility (ann.)
485%
SpaceX (bStocks Tokenized Stock)SPCXB

$133.8400

24h
-1.47%
Market cap
$196.41M
Volume 24h
$66.66M
Volatility (ann.)
71%
ENLVON 0.0%Share of the two combined market caps100.0% SPCXB

Performance

ENLVONSPCXB

  1. 7 days-19.59%-6.33%SPCXB
  2. 30 days-66.00%-21.79%SPCXB
  3. 90 days—+17.70%—

Correlation

0.06over 28 shared trading days

−1 opposite0 unrelated+1 in step
7d: insufficient data30d: 0.0690d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

MetricENLVONSPCXB
Max drawdown (400d)-76.0%-47.5%
Risk-adjusted return (90d)-0.140.28

Relative strength over 90 days: SPCXB outperformed ENLVON by 67.9% — measured on the ENLVON/SPCXB ratio, so it holds regardless of market direction.